CN Stock MarketDetailed Quotes
688221 Frontier Biotechnologies Inc.
- 5.71
- -0.47-7.61%
Market Closed Oct 11 15:00 CST
2.14BMarket Cap-6757P/E (TTM)
6.27High5.63Low70.82KlotVolume6.27Open6.18Pre Close41.43MTurnover1.89%Turnover RatioLossP/E (Static)374.58MShares11.5452wk High1.81P/B2.14BFloat Cap4.4852wk Low7.42Limit Up374.58MShs Float35.53Historical High4.94Limit Down10.36%Amplitude4.48Historical Low--Dividend TTM5.85Avg Price43.61KlotAsk--Div YieldTTM100Lot Size25.93KlotBid
Frontier Biotechnologies Inc. Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 86.33%75.2M | 211.57%38.81M | 33.31%108.03M | 35.41%64.43M | 24.39%40.36M | -7.12%12.46M | 47.83%81.04M | 13.56%47.58M | 8.23%32.45M | 85.02%13.41M |
| Refunds of taxes and levies | ---- | ---- | -82.20%10.14M | -88.93%5.73M | -88.93%5.73M | -61.07%5.73M | 291.37%56.97M | 255.49%51.75M | 300.77%51.75M | 136.54%14.71M |
| Cash received relating to other operating activities | -37.86%13.27M | -53.00%7.97M | -54.86%37.71M | -66.89%25.01M | -59.67%21.36M | -47.47%16.97M | 113.05%83.54M | 718.07%75.52M | 933.90%52.96M | 992.91%32.3M |
| Cash inflows from operating activities | 31.18%88.48M | 33.10%46.79M | -29.64%155.88M | -45.57%95.17M | -50.82%67.45M | -41.82%35.15M | 104.03%221.55M | 166.18%174.85M | 185.65%137.15M | 267.89%60.42M |
| Goods services cash paid | -51.32%19.79M | 25.99%7.82M | -29.99%62.99M | -78.29%44.41M | -69.48%40.65M | -82.21%6.2M | -48.28%89.97M | 111.19%204.53M | 150.60%133.18M | 55.25%34.88M |
| Staff behalf paid | -11.14%69.8M | -3.49%42.29M | -3.86%144.56M | -2.37%109.44M | 0.91%78.56M | -2.05%43.82M | 29.79%150.36M | 33.43%112.1M | 27.76%77.85M | 32.12%44.74M |
| All taxes paid | 43.30%2.39M | -3.10%484K | 28.41%3.76M | 22.27%2.17M | 17.74%1.67M | 37.67%499.5K | 27.29%2.92M | -0.62%1.77M | -13.51%1.42M | -46.36%362.81K |
| Cash paid relating to other operating activities | -19.71%85.68M | -25.02%39.95M | -20.79%211.75M | 243.86%148.79M | 256.07%106.71M | 258.79%53.28M | 348.94%267.34M | 7.19%43.27M | 40.44%29.97M | 21.26%14.85M |
| Cash outflows from operating activities | -21.93%177.67M | -12.78%90.54M | -17.14%423.05M | -15.72%304.81M | -6.12%227.59M | 9.46%103.8M | 45.20%510.59M | 62.18%361.67M | 76.87%242.41M | 36.94%94.83M |
| Net cash flows from operating activities | 44.30%-89.19M | 36.27%-43.75M | 7.57%-267.17M | -12.22%-209.64M | -52.13%-160.14M | -99.50%-68.65M | -18.91%-289.04M | -18.75%-186.82M | -18.22%-105.26M | 34.87%-34.41M |
| Investing cash flow | ||||||||||
| Cash received from returns on investments | -7.17%8.15M | -20.68%3.4M | -13.41%17.81M | -11.65%14.1M | -6.51%8.78M | 4.21%4.29M | -45.49%20.57M | -41.24%15.96M | -41.66%9.39M | -27.67%4.12M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -83.64%25.69K | -94.84%6.6K | 140,617.10%239.22K | 104,119.38%177.17K | 92,248.79%156.99K | 639,900.00%128K | -99.89%170 | --170 | --170 | -99.41%20 |
| Cash received relating to other investing activities | -22.68%1.77B | -0.76%861.4M | 36.41%4.75B | 44.03%3.56B | 44.82%2.29B | 28.21%868M | -39.99%3.48B | -37.46%2.47B | -31.99%1.58B | -33.50%677M |
| Cash inflows from investing activities | -22.62%1.78B | -0.87%864.81M | 36.12%4.77B | 43.68%3.57B | 44.53%2.3B | 28.09%872.42M | -40.02%3.5B | -37.48%2.49B | -32.05%1.59B | -33.46%681.12M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -82.33%14.82M | -86.08%9.95M | -7.85%129.35M | -26.84%88.62M | -19.25%83.83M | -1.32%71.5M | -57.09%140.37M | -47.96%121.12M | -17.75%103.82M | 32.80%72.45M |
| Cash paid relating to other investing activities | -12.81%1.89B | 63.95%1.16B | 28.35%4.47B | 38.97%3.15B | 41.53%2.17B | -1.12%709M | -37.09%3.48B | -46.92%2.27B | -41.81%1.53B | -45.10%717M |
| Cash outflows from investing activities | -15.40%1.91B | 50.21%1.17B | 26.94%4.59B | 35.63%3.24B | 37.67%2.25B | -1.13%780.5M | -38.21%3.62B | -46.98%2.39B | -40.71%1.64B | -41.98%789.45M |
| Net cash flows from investing activities | -361.22%-125.65M | -434.58%-307.55M | 247.27%172.7M | 235.88%335.66M | 208.27%48.1M | 184.85%91.92M | -542.16%-117.27M | 119.09%99.93M | 89.35%-44.43M | 67.84%-108.33M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | --195.67M | --196.31M | ---- | ---- |
| Cash from borrowing | 75.68%281.93M | -4.32%98.91M | 54.42%312.8M | 57.14%220.68M | 35.94%160.48M | 255.07%103.37M | -27.57%202.57M | -11.24%140.44M | -6.11%118.05M | --29.11M |
| Cash received relating to other financing activities | ---- | ---- | --41M | --41M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 75.68%281.93M | -4.32%98.91M | -11.16%353.8M | -22.29%261.68M | 35.94%160.48M | 255.07%103.37M | 42.39%398.23M | 112.82%336.75M | -6.11%118.05M | --29.11M |
| Borrowing repayment | 146.44%208.96M | 19.38%87.09M | -2.05%211.83M | 364.02%149.66M | 235.54%84.79M | 5,736.35%72.95M | 775.07%216.27M | 72.10%32.25M | 105.53%25.27M | -86.70%1.25M |
| Dividend interest payment | 22.30%8.68M | 14.51%4.08M | -4.45%14.46M | -5.60%11.15M | 261.76%7.1M | 318.66%3.57M | 172.97%15.13M | 263.12%11.82M | 26.75%1.96M | 152.54%851.76K |
| Cash payments relating to other financing activities | -97.39%1.31M | -87.10%1.14M | 676.65%57.22M | 559.69%51.24M | 808.30%50.1M | 89.82%8.82M | -75.53%7.37M | 19.41%7.77M | -4.20%5.52M | --4.65M |
| Cash outflows from financing activities | 54.20%218.95M | 8.17%92.32M | 18.74%283.51M | 309.08%212.06M | 333.59%141.99M | 1,164.24%85.34M | 295.56%238.77M | 81.89%51.84M | 67.08%32.75M | -30.67%6.75M |
| Net cash flows from financing activities | 240.67%62.98M | -63.44%6.59M | -55.92%70.29M | -82.58%49.62M | -78.33%18.49M | -19.38%18.03M | -27.29%159.46M | 119.62%284.91M | -19.62%85.3M | 329.66%22.36M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 220.55%6.48K | 105.13%885 | -130.97%-50.56K | 88.66%-38.32K | 98.18%-5.37K | -69.25%-17.25K | -28.36%163.26K | 3.66%-338.02K | -69.76%-295.59K | 93.35%-10.19K |
| Net increase in cash and cash equivalents | -62.31%-151.86M | -934.97%-344.71M | 90.18%-24.23M | -11.17%175.61M | -44.64%-93.56M | 134.29%41.28M | -490.43%-246.68M | 135.84%197.69M | 83.84%-64.68M | 69.87%-120.39M |
| Add:Begin period cash and cash equivalents | -4.40%526.4M | -4.40%526.4M | -30.94%550.63M | -30.94%550.63M | -30.94%550.63M | -30.94%550.63M | -4.98%797.31M | -4.98%797.31M | -4.98%797.31M | -4.98%797.31M |
| End period cash equivalent | -18.06%374.54M | -69.30%181.69M | -4.40%526.4M | -27.01%726.24M | -37.61%457.07M | -12.56%591.92M | -30.94%550.63M | 246.02%995M | 66.93%732.63M | 54.02%676.92M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | China Audit Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data